Edge Rewrite
// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a2ac07df2dea4c41

Jump to content

Stephen K. Burley

From Wikipedia, the free encyclopedia

Stephen K. Burley
Born (1957-11-13) November 13, 1957 (age 68)
EducationUniversity of Western Ontario (BS)
Exeter College, Oxford (MS, PhD)
Harvard University (MD)
Scientific career
InstitutionsRutgers University
Lilly Research Laboratories
Rockefeller University
Howard Hughes Medical Institute
Thesis Molecular arrangement in viruses studied by X-ray and neutron scattering and other physical techniques  (1983)
Andrew Miller

Stephen Kevin Burley is a British-born scientist, naturalized in both Canada and the United States. He is known as an expert in structural biology, proteomics, structure/fragment based drug discovery, and clinical medicine/oncology.

Early life and education

[edit]

Stephen Kevin Burley has a bachelor's degree in physics from the University of Western Ontario[1] and a D.Phil from Oxford University, England in Molecular Biophysics as a Rhodes scholar.[2]

He also has an M.D. from Harvard Medical School.[citation needed]

Career

[edit]

Burley worked with Gregory A. Petsko and William N. Lipscomb at MIT and Harvard. He was faculty at Howard Hughes Medical Institute and Rockefeller University. Burley co-founded Prospect Genomics, Inc,[3] a computational genomics pharma.

He was chief scientific officer of SGX Pharmaceuticals after it acquired Prospect. SGX was in turn merged with Eli Lilly in 2008, where Burley was a Distinguished Lilly Research Scholar in Lilly Research Laboratories.[4]

In 2012 Burley joined Rutgers[5] as director of the Center for Integrative Proteomics Research and became director of the RCSB PDB (US regional data center for the worldwide PDB) in 2014, succeeding Prof. Helen Berman[6]

Other activities

[edit]

As of June 2026, Burley is a member of the editorial board for Oncogene.[7]

Honors and awards

[edit]

References

[edit]
  1. "Structural GenomiX Appoints Stephen K. Burley as Chief Scientific Officer -- re> SAN DIEGO, Oct. 16 /PRNewswire/ --". Archived from the original on 13 October 2014.
  2. "Introducing Professor Stephen K. Burley | Department of Chemistry & Chemical Biology". Archived from the original on 14 October 2014. Retrieved 8 October 2014.
  3. "Stocks". 30 August 2023.[dead link]
  4. "Stephen K. Burley, M.D., D.Phil. | Center for Integrative Proteomics Research". proteomics.rutgers.edu. Archived from the original on 10 March 2016. Retrieved 26 February 2025.
  5. "Rutgers recruits top researcher to head Center for Integrative Proteomics Research - NJBIZ". 17 December 2012.
  6. "RCSB PDB - News". www.rcsb.org. Archived from the original on 3 September 2014.
  7. "Editorial Board". Oncogene. Retrieved 8 June 2026.